Meirong Huo
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems 8
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 35
- Molecular Medicine top 1%
- Pharmacology top 1%
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 25
-
- RNA Interference and Gene Delivery 9
-
- Immunotherapy and Immune Responses 8
-
- Cancer Treatment and Pharmacology 6
- CAR-T cell therapy research 4
-
- Dendrimers and Hyperbranched Polymers 5
- Co-authors
- Jianping ZhouShaofei XieYong ZhangAifeng ZouChengli YaoWeize LiTingjie YinLifang Yin
- Journals
- Biomaterials (7 papers)Journal of Controlled Release (6 papers)International Journal of Pharmaceutics (5 papers)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Meirong Huo
57 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Pharmaceutical Science 1.6k
- Biomaterials 1.9k
- Molecular Medicine 362
- Pharmacology 279
- Biomedical Engineering 1.4k
Countries citing papers authored by Meirong Huo
This map shows the geographic impact of Meirong Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meirong Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meirong Huo more than expected).
Fields of papers citing papers by Meirong Huo
This network shows the impact of papers produced by Meirong Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meirong Huo. The network helps show where Meirong Huo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meirong Huo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 17 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 45 | |
| 7 | 2022 | 51 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 19 | |
| 10 | 2020 | 21 | |
| 11 | 2018 | 81 | |
| 12 | 2017 | 27 | |
| 13 | 2016 | 41 | |
| 14 | 2015 | 21 | |
| 15 | 2015 | 141 | |
| 16 | 2015 | 59 | |
| 17 | 2015 | 143 | |
| 18 | 2015 | 68 | |
| 19 | PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excelbreakdown → | 2010 | 1675 |
| 20 | 2009 | 96 |
About Meirong Huo
Meirong Huo is a scholar working on Biomaterials, Pharmaceutical Science and Biomedical Engineering, having authored 58 papers that have together received 5.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (35 papers), Nanoplatforms for cancer theranostics (25 papers), RNA Interference and Gene Delivery (9 papers), Immunotherapy and Immune Responses (8 papers), Advanced Drug Delivery Systems (8 papers), Cancer Treatment and Pharmacology (6 papers), Dendrimers and Hyperbranched Polymers (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Pharmaceutical Science (1.6k citations), Biomaterials (1.9k citations) and Molecular Medicine (362 citations). Meirong Huo has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Jianping Zhou, Shaofei Xie, Yong Zhang, Jianping Zhou, Aifeng Zou, Chengli Yao, Weize Li, Yong Zhang, Tingjie Yin and Lifang Yin. Their work appears in journals such as Biomaterials, Journal of Controlled Release, International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Carbohydrate Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.